Correlation Between Verastem and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both Verastem and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verastem and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verastem and Cue Biopharma, you can compare the effects of market volatilities on Verastem and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verastem with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verastem and Cue Biopharma.
Diversification Opportunities for Verastem and Cue Biopharma
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Verastem and Cue is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Verastem and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and Verastem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verastem are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of Verastem i.e., Verastem and Cue Biopharma go up and down completely randomly.
Pair Corralation between Verastem and Cue Biopharma
Given the investment horizon of 90 days Verastem is expected to generate 0.71 times more return on investment than Cue Biopharma. However, Verastem is 1.41 times less risky than Cue Biopharma. It trades about 0.19 of its potential returns per unit of risk. Cue Biopharma is currently generating about -0.17 per unit of risk. If you would invest 374.00 in Verastem on August 31, 2024 and sell it today you would earn a total of 83.00 from holding Verastem or generate 22.19% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Verastem vs. Cue Biopharma
Performance |
| Timeline |
| Verastem |
| Cue Biopharma |
Verastem and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Verastem and Cue Biopharma
The main advantage of trading using opposite Verastem and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verastem position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.| Verastem vs. Cue Biopharma | Verastem vs. Tff Pharmaceuticals | Verastem vs. Eliem Therapeutics | Verastem vs. Inhibrx |
| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |